![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 08, 2013 3:55:08 PM
I think what some commentators, both here and elsewhere, are missing is that,
since the upcoming interim is based upon events(i.e. deaths), unless you believe that this control group is doing astoundingly better than the previous standard of care(while the tx group is doing much worse, both than 107's PH1, but also that of a number of competitors, employing similar paradigms),
you have to conclude that any interim, from here on in, is indicative of great improvement vs previous standard of care results.
And that is, despite ill-informed(probably for pay)naysayers like AF, all you need to know.
As you might imagine, I have and continue to hold a large position in imuc, and a small one in nwbo.
Recent IMUC News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/02/2023 07:11:57 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM